Hepatitis B Shots Advised for All US Adults Younger Than 60 Years
All U.S. adults younger than 60 years should be vaccinated against hepatitis B, the Advisory Committee on Immunization Practices recommended.
Viral Hepatitis
Effect of Sofosbuvir-Based Antivirals on Low-Density Lipoproteins in Patients With Hepatitis C Virus
Researchers conducted a study to determine the effect of treatment with sofosbuvir-based direct-acting antivirals on changes in low-density lipoprotein concentrations among patients with hepatitis C virus infection.
Efficacy of Long-Acting Cabotegravir Plus Rilpivirine in Patients With HIV Coinfected With Asymptomatic Hepatitis C
Researchers sought to determine the safety and efficacy of treatment with long-acting cabotegravir plus rilpivirine in patients with HIV coinfected with asymptomatic hepatitis c virus.
Projected Long-Term Impact of the COVID-19 Pandemic on Outcomes Associated With Hepatitis C Virus
Researchers conducted a modeling study to determine the projected long-term impact of the COVID-19 pandemic on outcomes associated with hepatitis C virus care.
Medication Treatments Lacking For Active Opioid Use Disorder in Veterans With Cirrhosis
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
Outcomes of Rapid Treatment With Sofosbuvir-Velpatasvir in Patients With Hepatitis C Virus who use Injectable Drugs
Researchers conducted a study that compared rapid treatment with a 7-day course of sofosbuvir-velpatasvir with usual compare in patients with hepatitis C virus infection who use injectable drugs.
Model Evaluates HCV Elimination Forecast Among People Who Inject Drugs
Based on a mathematical model, investigators evaluated improvements to the care cascade for people with hepatitis C virus who inject drugs.
Sleep-Wake Disturbance Highly Prevalent in Populations With Liver Disease
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Impact of Subscription-Based Payment Models on Hepatitis C Virus Prescription Fills Covered by Medicaid in Louisiana, Washington
Researchers conducted a cross-sectional study to assess the impact of subscription-based payment models on the rate of prescription fills for hepatitis C virus medications among individuals in Louisiana and Washington enrolled in Medicaid.
Hepatitis D: Recent Advances in Virology, Immunology and Treatment
Forty years after the emergence of HDV, the first anti-HDV therapeutic has been approved by the EMA, indicating the dawn of a new era for this difficult to treat disease
- Loading...
Loading...
Loading... 
Loading...